NCT04508790 2025-08-07Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple MyelomaCity of Hope Medical CenterPhase 2 Recruiting29 enrolled
NCT03952832 2019-11-14Leflunomide in Treating Patients With High-Risk Smoldering Multiple MyelomaCity of Hope Medical CenterPhase 2 Withdrawn